What are the best treatments for Achondroplasia?

The management of Achondroplasia focuses on monitoring for specific skeletal and neurological complications, with treatment plans tailored to the individual patient’s clinical needs rather than a universal protocol.

Medical and Pharmacological Interventions

While Achondroplasia is a genetic condition, therapeutic options have evolved significantly. The FDA-approved medication vosoritide (Voxzogo) is a C-type natriuretic peptide (CNP) analog designed to promote linear bone growth in children with open epiphyses. Treatment decisions regarding vosoritide should be made in consultation with a pediatric endocrinologist, as individual responses to therapy vary based on age and bone maturation.

Non-Pharmacological and Surgical Management

Standard care for Achondroplasia is supportive and preventative. Physical and occupational therapy are essential early in life to address motor delays and support joint health. Surgical interventions, such as decompression of the foramen magnum, may be necessary if there is evidence of spinal cord compression or obstructive sleep apnea. Orthopedic consultations are standard for managing spinal stenosis, kyphosis, or bowed legs (genu varum) that may cause pain or functional impairment.

Multidisciplinary Care

Because Achondroplasia affects multiple systems, a multidisciplinary team is vital. This team typically includes a clinical geneticist, pediatric endocrinologist, orthopedist, neurosurgeon, and physical therapist. Regular monitoring for complications like middle ear infections, dental crowding, and weight management is also a critical component of long-term health, as Achondroplasia requires lifelong coordination between these diverse specialists.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Treatment plans must be personalized by your primary healthcare team based on specific clinical findings. Always consult with your physician before making decisions regarding medication or surgical intervention.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Achondroplasia


• Orphanet: Achondroplasia (ORPHA:15)


• OMIM (Online Mendelian Inheritance in Man): Achondroplasia


• Little People of America (LPA) Medical Resources